|

GLP-1 receptor agonist Clinical Trials

5 actively recruiting trials across 2 locations

▼ -1 trial since June 2026

Also known as: GLP-1 agonists, Semaglutide, dulaglutide, exenatide, liraglutide +2 more

Pipeline

Phase 4: 2

Top Sponsors

  • University of Missouri-Columbia1
  • The Affiliated Hospital of Xuzhou Medical University1
  • Lia Bally1
  • Cardenal Herrera University1
  • Brigham and Women's Hospital1

Indications

  • Diabetes5
  • Obstructive Sleep Apnea of Adult1
  • Chronic Kidney Disease Stage 21
  • Chronic Kidney Disease Stage 11
  • Chronic Kidney Disease stage41

Other3 trials

Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
N/A
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes
N/A

Huntsville, Alabama1 trial

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Longwood Research LLC

Phase 4

Columbia, Missouri1 trial

Impact GLP-1 Agonists Following Bariatric

University of Missouri Hospital

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.